Edition:
United States

Immunomedics Inc (IMMU.OQ)

IMMU.OQ on NASDAQ Stock Exchange Global Market

18.71USD
3:59pm EST
Change (% chg)

$0.22 (+1.19%)
Prev Close
$18.49
Open
$18.19
Day's High
$19.30
Day's Low
$17.82
Volume
593,567
Avg. Vol
561,623
52-wk High
$27.32
52-wk Low
$8.68

Chart for

About

Immunomedics, Inc. is a clinical-stage biopharmaceutical company. The Company is engaged in developing monoclonal antibody-based products for the targeted treatment of cancer, autoimmune disorders and other serious diseases. Its geographic segments include United States and Europe. Its technologies allow it to create humanized... (more)

Overall

Beta: 1.91
Market Cap(Mil.): $3,576.17
Shares Outstanding(Mil.): 190.02
Dividend: --
Yield (%): --

Financials

  IMMU.OQ Industry Sector
P/E (TTM): -- 79.36 29.34
EPS (TTM): -1.23 -- --
ROI: -83.13 -0.30 13.58
ROE: -158.22 -2.98 15.11

BRIEF-Immunomedics Submits Biologics License Application For Sacituzumab Govitecan To The U.S. FDA

* IMMUNOMEDICS SUBMITS BIOLOGICS LICENSE APPLICATION FOR SACITUZUMAB GOVITECAN TO THE U.S. FOOD AND DRUG ADMINISTRATION

May 21 2018

Earnings vs. Estimates